Allscripts Healthcare Solutions Company Profile (NASDAQ:MDRX)

About Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare Solutions logoAllscripts Healthcare Solutions, Inc. (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions. The Population Health segment includes the sale of health management and coordinated care solutions, which focus on hospitals, health systems, other care facilities and accountable care organizations (ACOs). The Netsmart segment provides software and technology solutions to the health and human services industry, which includes behavioral health, addiction treatment, intellectual and developmental disability services, child and family services and public health segments, as well as to post-acute home care organizations.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Software & Technology Services
  • Sub-Industry: Health Care Technology
  • Symbol: NASDAQ:MDRX
  • CUSIP: 01988P10
  • Web:
  • Market Cap: $2.54302 billion
  • Outstanding Shares: 180,612,000
Average Prices:
  • 50 Day Moving Avg: $13.83
  • 200 Day Moving Avg: $12.71
  • 52 Week Range: $9.80 - $14.45
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 24.70
  • P/E Growth: 1.27
Sales & Book Value:
  • Annual Revenue: $1.66 billion
  • Price / Sales: 1.53
  • Book Value: $6.23 per share
  • Price / Book: 2.26
  • EBITDA: $160.09 million
  • Net Margins: -11.54%
  • Return on Equity: 5.97%
  • Return on Assets: 1.96%
  • Debt-to-Equity Ratio: 1.13%
  • Current Ratio: 0.93%
  • Quick Ratio: 0.93%
  • Average Volume: 2.40 million shs.
  • Beta: 1.31
  • Short Ratio: 9.63

Frequently Asked Questions for Allscripts Healthcare Solutions (NASDAQ:MDRX)

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) issued its quarterly earnings data on Thursday, August, 3rd. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by $0.04. The company had revenue of $426.10 million for the quarter, compared to analysts' expectations of $424.94 million. Allscripts Healthcare Solutions had a negative net margin of 11.54% and a positive return on equity of 5.97%. The company's revenue for the quarter was up 10.2% on a year-over-year basis. During the same quarter last year, the company earned $0.14 earnings per share. View Allscripts Healthcare Solutions' Earnings History.

When will Allscripts Healthcare Solutions make its next earnings announcement?

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Thursday, November, 2nd 2017. View Earnings Estimates for Allscripts Healthcare Solutions.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions updated its FY17 earnings guidance on Thursday, August, 3rd. The company provided earnings per share guidance of $0.61-0.63 for the period, compared to the Thomson Reuters consensus estimate of $0.62.

Where is Allscripts Healthcare Solutions' stock going? Where will Allscripts Healthcare Solutions' stock price be in 2017?

19 brokerages have issued 1-year price targets for Allscripts Healthcare Solutions' stock. Their predictions range from $12.00 to $19.00. On average, they anticipate Allscripts Healthcare Solutions' share price to reach $15.24 in the next year. View Analyst Ratings for Allscripts Healthcare Solutions.

What are analysts saying about Allscripts Healthcare Solutions stock?

Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:

  • 1. According to Zacks Investment Research, "Over the last year, Allscripts has traded below the broader industry in terms of price. Allscripts exited the second quarter on a favorable note, wherein adjusted earnings were in line with the Zacks Consensus Estimate, while revenues beat the same. A solid guidance for full-year 2017 and a strong long-term outlook are the key highlights at the moment. Allscripts announced its plans to takeover the hospital and health system business from McKesson Corporation, which is expected to close by the fourth quarter. Allscripts’ continued reliance on mergers and acquisition activities presents a substantial integration risk for the company. Furthermore, intensifying market competition is a major dampener for Allscripts. The company also expects a modest increase in operating expenses during the second half of the year to support business growth." (10/10/2017)
  • 2. Cantor Fitzgerald analysts commented, "2Q17 recap. Non-GAAP revenue was $428 million compared to FactSet consensus of $426 million. With Netsmart now mostly annualized, non-GAAP revenue grew 7.8% y/y. Adjusted EPS was $0.15 (in line with our estimate and consensus) vs. $0.14 a year ago. Bookings were impressive and grew to $407 million." (8/14/2017)
  • 3. Maxim Group analysts commented, "1Q17 bookings of $286M, up 13.5% y/y, were below our estimate of $302M and consensus of $298M." (5/5/2017)
  • 4. Citigroup Inc. analysts commented, "We are upgrading MDRX shares to Buy following its recent analyst day. Allscripts provided targets for 2018 - 2020 revenue growth of 6%-8% and EPS growth of 12%-15%, both of which are ahead of our forecasts but approximately in-line with the Street. Allscripts is beginning to show better results as non-recurring revenue has stabilized, recurring revenue grows faster, and the mix continues to shift to recurring revenue, with non EMR solutions seeing faster growth. We believe that if Allscripts can hit these targets investors could see a 20% return on the shares this year from current levels." (3/24/2017)
  • 5. Piper Jaffray Companies analysts commented, "We attended Allscripts' Investor Conference yesterday where management discussed its plan to deliver its FY17 guidance and long term growth targets. We believe 6-8% revenue growth and 12-15% EPS growth are achievable, provided the non-recurring revenue has surpassed its decline, and the Platform as a Service model continues to grow. We are tapering our FY18 EPS estimate to be in line with targets while maintaining our 20x EPS valuation, which brings our PT to $14 from $15. Reiterate Neutral." (3/22/2017)

Are investors shorting Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions saw a drop in short interest in the month of September. As of September 15th, there was short interest totalling 20,145,704 shares, a drop of 16.7% from the August 31st total of 24,175,514 shares. Based on an average daily trading volume, of 2,996,129 shares, the days-to-cover ratio is presently 6.7 days. Currently, 11.4% of the shares of the company are short sold.

Who are some of Allscripts Healthcare Solutions' key competitors?

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the folowing people:

  • Michael A. Klayko, Independent Chairman of the Board
  • Richard J. Poulton, President
  • Paul M. Black, Chief Executive Officer, Director
  • Dennis M. Olis, Interim Chief Financial Officer, Principal Accounting Officer
  • James R. Hewitt, Executive Vice President, Solutions Development
  • Lisa Khorey, Executive Vice President, Chief Client Delivery Officer
  • Brian P. Farley, Senior Vice President, General Counsel and Corporate Secretary;
  • Mara Glickman Aspinall, Independent Director
  • P. Gregory Garrison, Independent Director
  • Jonathan J. Judge, Independent Director

Who owns Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (1.30%), Mutual of America Capital Management LLC (0.08%), Tributary Capital Management LLC (0.07%) and State Treasurer State of Michigan (0.04%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Paul Black and Richard J Poulton. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

Who sold Allscripts Healthcare Solutions stock? Who is selling Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock was sold by a variety of institutional investors in the last quarter, including State Treasurer State of Michigan and Mutual of America Capital Management LLC. Company insiders that have sold Allscripts Healthcare Solutions stock in the last year include Brian Farley, Paul Black and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Who bought Allscripts Healthcare Solutions stock? Who is buying Allscripts Healthcare Solutions stock?

Allscripts Healthcare Solutions' stock was purchased by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC and Tributary Capital Management LLC. View Insider Buying and Selling for Allscripts Healthcare Solutions.

How do I buy Allscripts Healthcare Solutions stock?

Shares of Allscripts Healthcare Solutions can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Allscripts Healthcare Solutions' stock price today?

One share of Allscripts Healthcare Solutions stock can currently be purchased for approximately $14.08.

MarketBeat Community Rating for Allscripts Healthcare Solutions (NASDAQ MDRX)
Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  423 (Vote Outperform)
Underperform Votes:  444 (Vote Underperform)
Total Votes:  867
MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Allscripts Healthcare Solutions (NASDAQ:MDRX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings, 12 Buy Ratings
Consensus Rating:Buy (Score: 2.58)
Consensus Price Target: $15.24 (8.21% upside)
Consensus Price Target History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Price Target History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Analysts' Ratings History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/17/2017Robert W. BairdReiterated RatingBuy$16.00N/AView Rating Details
10/3/2017Dougherty & CoReiterated RatingBuy$15.00 -> $16.00LowView Rating Details
9/27/2017Cantor FitzgeraldReiterated RatingBuy$17.00LowView Rating Details
9/19/2017Royal Bank Of CanadaInitiated CoverageOutperform -> Outperform$17.00MediumView Rating Details
9/11/2017Cowen and CompanyUpgradeMarket Perform -> Outperform$13.00 -> $16.00HighView Rating Details
8/25/2017Jefferies Group LLCSet Price TargetBuy$17.00LowView Rating Details
8/7/2017Citigroup Inc.Boost Price TargetNeutral$13.00 -> $14.00LowView Rating Details
8/7/2017Morgan StanleyBoost Price TargetUnderweight$11.00 -> $12.00LowView Rating Details
8/4/2017Maxim GroupReiterated RatingBuy$16.00HighView Rating Details
7/21/2017Piper Jaffray CompaniesReiterated RatingHold$14.00LowView Rating Details
6/19/2017Leerink SwannDowngradeOutperform -> Market Perform$15.00 -> $13.00MediumView Rating Details
5/15/2017Bank of America CorporationInitiated CoverageNeutral$14.00HighView Rating Details
3/27/2017Wells Fargo & CompanyUpgradeMarket Perform -> OutperformHighView Rating Details
3/24/2017Deutsche Bank AGUpgradeHold -> Buy$12.50 -> $14.00LowView Rating Details
2/17/2017Oppenheimer Holdings, Inc.Reiterated RatingHoldN/AView Rating Details
1/8/2017FBR & CoReiterated RatingHold$12.00N/AView Rating Details
1/3/2017Canaccord GenuityReiterated RatingBuy$17.00N/AView Rating Details
10/30/2016J P Morgan Chase & CoInitiated CoverageBuy$15.00N/AView Rating Details
10/23/2016ArgusReiterated RatingBuy$19.00N/AView Rating Details
8/5/2016Goldman Sachs Group, Inc. (The)Boost Price TargetNeutral$14.00 -> $16.00N/AView Rating Details
5/22/2016KeyCorpReiterated RatingHoldN/AView Rating Details
2/24/2016SunTrust Banks, Inc.Lower Price TargetBuy$18.00 -> $15.00N/AView Rating Details
2/19/2016Barclays PLCLower Price TargetEqual Weight$15.00 -> $14.00N/AView Rating Details
1/5/2016Topeka Capital MarketsBoost Price TargetHold$14.00 -> $15.00N/AView Rating Details
1/4/2016Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
11/6/2015Evercore ISIBoost Price TargetHold$14.00 -> $15.00N/AView Rating Details
(Data available from 10/22/2015 forward)


Earnings History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Earnings by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Earnings History by Quarter for Allscripts Healthcare Solutions (NASDAQ MDRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/1/2017$0.16N/AView Earnings Details
8/3/2017Q2 2017$0.15$0.11$424.94 million$426.10 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.09$0.10$415.20 million$415.00 millionViewListenView Earnings Details
2/16/2017Q4 2016$0.15$0.14$424.11 million$425.40 millionViewListenView Earnings Details
11/3/2016Q3$0.15$0.14$414.92 million$392.40 millionViewListenView Earnings Details
8/4/2016Q2$0.14$0.14$403.13 million$386.50 millionViewListenView Earnings Details
5/5/2016Q1$0.12$0.13$348.51 million$346.00 millionViewListenView Earnings Details
2/18/2016Q4$0.13$0.13$357.91 million$345.60 millionViewListenView Earnings Details
11/5/2015Q315$0.12$0.13$354.67 million$355.00 millionViewListenView Earnings Details
8/4/2015Q215$0.11$0.12$347.13 million$351.70 millionViewListenView Earnings Details
5/7/2015Q115$0.09$0.08$344.73 million$335.00 millionViewListenView Earnings Details
2/26/2015Q414$0.09$0.09$358.10 million$343.00 millionViewListenView Earnings Details
11/6/2014Q314$0.10$0.06$353.00 million$348.00 millionViewListenView Earnings Details
8/7/2014Q214$0.09$0.09$353.12 million$351.30 millionViewListenView Earnings Details
5/8/2014Q114$0.07$0.07$347.98 billion$340.30 billionViewListenView Earnings Details
2/20/2014Q413$0.08$0.08$343.47 million$351.00 millionViewListenView Earnings Details
11/7/2013Q313$0.08$0.05$355.30 million$334.00 millionViewListenView Earnings Details
8/8/2013Q2 2013$0.11$0.09$360.00 million$344.80 millionViewListenView Earnings Details
5/9/2013Q1 2013$0.14$0.09$368.11 million$347.10 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.21$0.16$367.07 million$367.70 millionViewListenView Earnings Details
11/8/2012Q312$0.22$0.23$376.97 million$361.00 millionViewN/AView Earnings Details
8/8/2012$0.18$0.16ViewN/AView Earnings Details
4/26/2012$0.24$0.12ViewN/AView Earnings Details
2/16/2012$0.25$0.25ViewN/AView Earnings Details
11/3/2011$0.22$0.25ViewN/AView Earnings Details
8/2/2011$0.21$0.22ViewN/AView Earnings Details
5/5/2011$0.20$0.21ViewN/AView Earnings Details
2/15/2011$0.18$0.20ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Allscripts Healthcare Solutions (NASDAQ:MDRX)
2017 EPS Consensus Estimate: $0.47
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.08$0.11$0.10
Q2 20174$0.10$0.12$0.11
Q3 20175$0.11$0.13$0.12
Q4 20173$0.12$0.15$0.14
(Data provided by Zacks Investment Research)


Dividend History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Insider Ownership Percentage: 0.75%
Insider Trades by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Insider Trades by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/15/2017Richard J. PoultonPresidentSell15,000$13.56$203,400.00View SEC Filing  
9/14/2017Brian FarleyEVPSell5,000$13.52$67,600.00View SEC Filing  
9/14/2017Paul BlackCEOSell15,000$13.52$202,800.00View SEC Filing  
5/16/2017Richard J PoultonPresidentSell25,000$12.06$301,500.00View SEC Filing  
3/23/2017Brian FarleySVPSell15,000$11.63$174,450.00View SEC Filing  
9/15/2016James HewittSVPSell17,500$13.00$227,500.00View SEC Filing  
9/15/2016Paul BlackCEOSell15,000$13.00$195,000.00View SEC Filing  
7/11/2016Dennis OlisSVPSell7,000$14.00$98,000.00View SEC Filing  
7/1/2016James HewittSVPSell17,500$13.00$227,500.00View SEC Filing  
6/13/2016Paul BlackCEOSell15,000$13.04$195,600.00View SEC Filing  
6/13/2016Richard J PoultonPresidentSell10,000$13.03$130,300.00View SEC Filing  
4/7/2016Dennis OlisSVPSell25,000$14.00$350,000.00View SEC Filing  
3/30/2016James HewittSVPSell17,500$13.31$232,925.00View SEC Filing  
3/30/2016Paul BlackCEOSell15,000$13.31$199,650.00View SEC Filing  
3/14/2016Richard J PoultonPresidentSell5,000$12.85$64,250.00View SEC Filing  
8/17/2015James HewittSVPSell70,000$14.17$991,900.00View SEC Filing  
12/12/2014Paul BlackCEOBuy6,500$11.51$74,815.00View SEC Filing  
11/18/2014Anita PramodaDirectorBuy2,017$12.25$24,708.25View SEC Filing  
11/13/2014Dennis ChookaszianDirectorBuy10,000$12.43$124,300.00View SEC Filing  
11/11/2014Dennis OlisSVPBuy4,400$11.26$49,544.00View SEC Filing  
11/11/2014Paul BlackCEOBuy22,180$11.26$249,746.80View SEC Filing  
11/11/2014Richard J PoultonCFOBuy4,500$11.26$50,670.00View SEC Filing  
11/11/2014Stuart L BascombDirectorBuy6,743$11.26$75,926.18View SEC Filing  
8/18/2014Michael KlaykoDirectorBuy3,500$14.41$50,435.00View SEC Filing  
3/13/2014Deborah SnowSVPSell14,740$18.75$276,375.00View SEC Filing  
11/21/2013Deborah SnowSVPSell2,400$14.70$35,280.00View SEC Filing  
9/9/2013Clifford B MeltzerEVPSell35,000$14.56$509,600.00View SEC Filing  
8/15/2013Michael KlaykoDirectorBuy10,000$14.80$148,000.00View SEC Filing  
5/30/2013Deborah SnowSVPSell1,495$13.71$20,496.45View SEC Filing  
5/20/2013Stuart L BascombDirectorBuy3,701$14.02$51,888.02View SEC Filing  
5/15/2013Paul BlackCEOBuy7,120$14.02$99,822.40View SEC Filing  
5/14/2013Steve ShuteVPSell14,612$14.10$206,029.20View SEC Filing  
3/12/2013Paul BlackCEOBuy23,625$12.69$299,801.25View SEC Filing  
3/12/2013Stuart L BascombDirectorBuy10,000$12.64$126,400.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Latest Headlines for Allscripts Healthcare Solutions (NASDAQ:MDRX)
Loading headlines, please wait.



Allscripts Healthcare Solutions (MDRX) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.